Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Management of sulfur mustard-induced chronic pruritus: a review of clinical trials.

Panahi Y, Sarayani A, Beiraghdar F, Amiri M, Davoudi SM, Sahebkar A.

Cutan Ocul Toxicol. 2012 Sep;31(3):220-5. doi: 10.3109/15569527.2011.631655. Review.

PMID:
22085409
2.

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

Panahi Y, Sahebkar A, Amiri M, Davoudi SM, Beiraghdar F, Hoseininejad SL, Kolivand M.

Br J Nutr. 2012 Oct;108(7):1272-9.

PMID:
22099425
3.

Investigation of serum substance P status in patients with chronic pruritic skin lesions due to sulfur mustard: a cross-sectional study.

Panahi Y, Taherzadeh ES, Davoudi SM, Sahebkar A, Ranjbar R.

Cutan Ocul Toxicol. 2013 Mar;32(1):4-8. doi: 10.3109/15569527.2012.686077.

PMID:
22681041
4.

Baicalin as a potentially promising drug for the management of sulfur mustard induced cutaneous complications: a review of molecular mechanisms.

Sahebkar A.

Cutan Ocul Toxicol. 2012 Sep;31(3):226-34. doi: 10.3109/15569527.2011.633950. Review.

PMID:
22107027
5.

Relationship between levels of IFNγ, TNFα, and TGFβ and pruritus in sulfur mustard-exposed veterans.

Panahi Y, Davoudi SM, Beiraghdar F, Saadat A, Sahebkar A.

J Immunotoxicol. 2013 Apr-Jun;10(2):173-7. doi: 10.3109/1547691X.2012.707697.

PMID:
22994697
6.

Doxepin cream vs betamethasone cream for treatment of chronic skin lesions due to sulfur mustard.

Panahi Y, Davoudi SM, Beiraghdar F, Amiri M.

Skinmed. 2011 May-Jun;9(3):152-8.

PMID:
21675494
7.

Pathogenesis and treatment of skin lesions caused by sulfur mustard.

Poursaleh Z, Ghanei M, Babamahmoodi F, Izadi M, Harandi AA, Emadi SE, Taghavi NO, Sayad-Nouri SS, Emadi SN.

Cutan Ocul Toxicol. 2012 Sep;31(3):241-9. doi: 10.3109/15569527.2011.636119. Review.

PMID:
22122127
8.

Serum levels of interleukins 2, 4, 6, and 10 in veterans with chronic sulfur mustard-induced pruritus: a cross-sectional study.

Panahi Y, Davoudi SM, Beiraghdar F, Amiri M, Saadat A, Marzony ET, Naghizadeh MM, Sahebkar A.

Skinmed. 2013 Jul-Aug;11(4):205-9.

PMID:
24053005
9.

Acute and chronic effects of sulfur mustard on the skin: a comprehensive review.

Ghanei M, Poursaleh Z, Harandi AA, Emadi SE, Emadi SN.

Cutan Ocul Toxicol. 2010 Dec;29(4):269-77. doi: 10.3109/15569527.2010.511367. Review.

PMID:
20868209
10.

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

Panahi Y, Sahebkar A, Parvin S, Saadat A.

Ann Clin Biochem. 2012 Nov;49(Pt 6):580-8. doi: 10.1258/acb.2012.012040.

11.

Comparison of topical capsaicin and betamethasone in the treatment of chronic skin lesions due to sulfur mustard exposure.

Panahi Y, Davoudi SM, Moharamzad Y, Beiraghdar F, Naghizadeh MM.

Cutan Ocul Toxicol. 2008;27(3):203-11. doi: 10.1080/15569520802143519.

PMID:
18988089
12.

Comparison of clinical efficacy of topical pimecrolimus with betamethasone in chronic skin lesions due to sulfur mustard exposure: a randomized, investigator-blind study.

Panahi Y, Moharamzad Y, Beiraghdar F, Naghizadeh MM.

Basic Clin Pharmacol Toxicol. 2009 Feb;104(2):171-5. doi: 10.1111/j.1742-7843.2008.00356.x.

13.

A clinicopathological approach to sulfur mustard-induced organ complications: a major review.

Ghasemi H, Owlia P, Jalali-Nadoushan MR, Pourfarzam S, Azimi G, Yarmohammadi ME, Shams J, Fallahi F, Moaiedmohseni S, Moin A, Yaraee R, Vaez-Mahdavi MR, Faghihzadeh S, Mohammad Hassan Z, Soroush MR, Naghizadeh MM, Ardestani SK, Ghazanfari T.

Cutan Ocul Toxicol. 2013 Oct;32(4):304-24. doi: 10.3109/15569527.2013.781615. Review.

PMID:
23590683
14.

Efficacy of Aloe vera/olive oil cream versus betamethasone cream for chronic skin lesions following sulfur mustard exposure: a randomized double-blind clinical trial.

Panahi Y, Davoudi SM, Sahebkar A, Beiraghdar F, Dadjo Y, Feizi I, Amirchoopani G, Zamani A.

Cutan Ocul Toxicol. 2012 Jun;31(2):95-103. doi: 10.3109/15569527.2011.614669.

PMID:
21988705
15.

Cutaneous and ocular late complications of sulfur mustard in Iranian veterans.

Shohrati M, Peyman M, Peyman A, Davoudi M, Ghanei M.

Cutan Ocul Toxicol. 2007;26(2):73-81. Review. Erratum in: Cutan Ocul Toxicol. 2007;26(3):277.

PMID:
17612976
16.

Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure.

Panahi Y, Davoodi SM, Khalili H, Dashti-Khavidaki S, Bigdeli M.

Singapore Med J. 2007 May;48(5):392-5.

17.

Long-term skin damage due to chemical weapon exposure.

Firooz A, Sadr B, Davoudi SM, Nassiri-Kashani M, Panahi Y, Dowlati Y.

Cutan Ocul Toxicol. 2011 Mar;30(1):64-8. doi: 10.3109/15569527.2010.529547.

PMID:
21047269
18.

Comparison late cutaneous complications between exposure to sulfur mustard and nerve agents.

Emadi SN, Aslani J, Poursaleh Z, Izadi M, Soroush M, Kafashi M, Alavinia SA, Bakhshi H, Karimi A, Momtaz-Manesh K, Babaei AA, Esmaili A, Raygan B, Emadi SE, Babamahmoodi F, Emadi SA.

Cutan Ocul Toxicol. 2012 Sep;31(3):214-9. doi: 10.3109/15569527.2011.641196.

PMID:
22187952
19.

Sulfur mustard toxicity: history, chemistry, pharmacokinetics, and pharmacodynamics.

Ghabili K, Agutter PS, Ghanei M, Ansarin K, Panahi Y, Shoja MM.

Crit Rev Toxicol. 2011 May;41(5):384-403. doi: 10.3109/10408444.2010.541224. Review.

PMID:
21329486
20.

Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans.

Panahi Y, Davoudi SM, Sadr SB, Naghizadeh MM, Mohammadi-Mofrad M.

Int J Dermatol. 2008 Jun;47(6):557-61. doi: 10.1111/j.1365-4632.2008.03650.x.

PMID:
18477143
Items per page

Supplemental Content

Support Center